quantisnow
FeedTopReportsPricing
⌘K
Live feed
17:31:20·77d
INSIDERFiling
Revelation Biosciences Inc. logo

Director Roper Jess covered exercise/tax liability with 1,591 shares, decreasing direct ownership by 11% to 12,828 units (SEC Form 4)

REVB· Revelation Biosciences Inc.
Health Care
Original source

Companies

  • REVB
    Revelation Biosciences Inc.
    Health Care

Recent analyst ratings

  • Feb 17UpdateRoth Capital$12.00

Related

  • SEC8d
    SEC Form S-8 filed by Revelation Biosciences Inc.
  • NEWS17d
    Revelation Biosciences Announces Formation of Acute Kidney Injury Advisory Board
  • NEWS24d
    Revelation Biosciences Inc. Presents Additional Positive Data from Prime Clinical Study
  • NEWS30d
    REMINDER: Revelation Biosciences to Host Fireside Chat at 38th Annual Roth Conference
  • SEC35d
    Revelation Biosciences Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
  • NEWS35d
    Revelation Biosciences to Host Fireside Chat at 38th Annual Roth Conference
  • SEC56d
    Revelation Biosciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
  • NEWS56d
    Revelation Biosciences, Inc. Announces Financial Results For the Three and Twelve Months Ended December 31, 2025
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022